Guardian Pharmacy of Florida was awarded Florida Assisted Living Association’s 2024 Associate Member of the Year award at this year’s annual conference. The award recognizes associate member businesses who have been longtime members and supporters of the association and have been actively involved in FALA events through participation in the annual conference, chapter meetings, Legislative
GuardianShield’s Clinical Intervention Program: Ensuring Medication Safety and Resident Well-being Adverse drug events (ADEs) are a common cause of unplanned hospitalizations, increasing morbidity, mortality, and healthcare costs. Each year, they account for over 3.5 million doctor’s office visits, 1 million emergency room visits, and 125,000 hospital admissions. However, nearly half of these events are preventable.
At Guardian Pharmacy, we recognize the importance of staying informed and connected within the long-term care field, which touches the lives of countless individuals and families. That’s why we are thrilled to announce the launch of our new LinkedIn newsletter: Guardian’s Monthly Minute. What You Can Expect Each month, Guardian’s Monthly Minute will provide insightful
![Alzheimer’s disease is a devastating condition that affects millions of people worldwide, particularly older adults. This year, Guardian Pharmacy is proud to announce the Alzheimer's Association as our charity of choice. We recognize the critical importance of addressing this pervasive disease and supporting those affected by it. With each of our 48+ locations nationwide, we have a unique opportunity to make a significant impact in the communities we serve. Here’s why we’ve chosen to stand with the Alzheimer’s Association and how you can join us in making a difference. The Prevalence and Impact of Alzheimer’s Disease Alzheimer’s disease is a common condition among older adults, and its prevalence increases with age. Despite a slight decline in the proportion of older adults with dementia from 13% in 2011 to 10% in 2019, demographic shifts, particularly the aging baby boomer generation, are expected to drive an overall increase in the number of individuals affected by this disease. Quick Facts By age 65, approximately 10% of individuals are affected, a figure that escalates to as high as 50% among those aged 85 and older The diagnosis rate for Alzheimer’s doubles every five years beyond age 65 More than 7 million people aged 65 and older had dementia in 2020, a number that could surpass 9 million by 2030 and nearly 12 million by 2040 if current trends continue. The prevalence of Alzheimer's disease, related dementia, or cognitive impairment is high among nursing home residents, exceeding 40%. This statistic underscores the urgent need for specialized care and support within long-term care facilities, a demand set to grow alongside the projected rise in dementia cases in the coming decades. Dementia, encompassing Alzheimer’s disease and related disorders, profoundly impacts memory, cognition, and social functioning, severely curtailing independence and necessitating extensive caregiving. Not only does dementia take an emotional toll on families, but caring for a person living with dementia is also more expensive and time-consuming than other conditions common at older ages. Why Guardian is Committed Guardian Pharmacy serves more than 162,000 residents of long-term care facilities across the U.S. As a provider of pharmacy services to a large number of residents who may be affected by Alzheimer's disease, we see firsthand the impact this condition has on individuals, their families, and their caregivers. By choosing the Alzheimer's Association as our charity of choice for 2024, we are committing to support an organization that works tirelessly to advance dementia care and support those affected by Alzheimer's disease. This cause not only enhances our presence in our communities but also shows solidarity with the many individuals we serve who are directly affected by this disease. The Collective Impact Joining the Alzheimer's Association community of fundraisers has a profound impact. In FY23, contributions to the Alzheimer’s Association from donors and partners totaled over $374 million, directly supporting those affected by Alzheimer's and advancing research. The Walk to End Alzheimer's alone raised $89.5 million, engaging over 300,000 participants. Strategic fundraising efforts across various platforms have shown significant results, demonstrating the power of collective action in the fight against Alzheimer's. Together, we can make a real difference. What We’re Doing Each Guardian Pharmacy location is encouraged to form a team and connect with their local Alzheimer's Association chapter. Whether it’s participating in a Walk or Ride to End Alzheimer's, hosting educational events, or volunteering, each pharmacy’s involvement in their local community can create a meaningful contribution. For example, the Birmingham, Alabama pharmacy team showed incredible community spirit by rallying its employees to support The Alzheimer’s Association’s The Longest Day on June 20th through a baked goods silent auction. This event not only raised funds but also increased awareness about Alzheimer's disease within their community. [Read more about the Birmingham team's efforts] Our Goal Our goal for 2024 is for each of our 48+ pharmacy locations and our corporate support services to commit to building a team and getting involved. We recognize that no action is too small to make a big difference in the fight to #ENDALZ. Join Us in the Fight to #ENDALZ We invite everyone to join us in our stand against Alzheimer’s in 2024. Getting involved is easy. Sign up for an Alzheimer's Event near you, find volunteer opportunities in your community, or start your fundraiser event. By coming together as a community, we can make a significant impact in the fight against Alzheimer's disease. Join Guardian Pharmacy in supporting the Alzheimer’s Association and help us work towards a future without this devastating condition. Together, we can #ENDALZ.](https://guardianpharmacy.com/wp-content/uploads/2024/07/Purple-Ribbon-1179x500-1-620x265.jpg "Alzheimer’s disease is a devastating condition that affects millions of people worldwide, particularly older adults. This year, Guardian Pharmacy is proud to announce the Alzheimer’s Association as our charity of choice. We recognize the critical importance of addressing this pervasive disease and supporting those affected by it. With each of our 48+ locations nationwide, we have a unique opportunity to make a significant impact in the communities we serve. Here’s why we’ve chosen to stand with the Alzheimer’s Association and how you can join us in making a difference. The Prevalence and Impact of Alzheimer’s Disease Alzheimer’s disease is a common condition among older adults, and its prevalence increases with age. Despite a slight decline in the proportion of older adults with dementia from 13% in 2011 to 10% in 2019, demographic shifts, particularly the aging baby boomer generation, are expected to drive an overall increase in the number of individuals affected by this disease. Quick Facts By age 65, approximately 10% of individuals are affected, a figure that escalates to as high as 50% among those aged 85 and older The diagnosis rate for Alzheimer’s doubles every five years beyond age 65 More than 7 million people aged 65 and older had dementia in 2020, a number that could surpass 9 million by 2030 and nearly 12 million by 2040 if current trends continue. The prevalence of Alzheimer’s disease, related dementia, or cognitive impairment is high among nursing home residents, exceeding 40%. This statistic underscores the urgent need for specialized care and support within long-term care facilities, a demand set to grow alongside the projected rise in dementia cases in the coming decades. Dementia, encompassing Alzheimer’s disease and related disorders, profoundly impacts memory, cognition, and social functioning, severely curtailing independence and necessitating extensive caregiving. Not only does dementia take an emotional toll on families, but caring for a person living with dementia is also more expensive and time-consuming than other conditions common at older ages. Why Guardian is Committed Guardian Pharmacy serves more than 162,000 residents of long-term care facilities across the U.S. As a provider of pharmacy services to a large number of residents who may be affected by Alzheimer’s disease, we see firsthand the impact this condition has on individuals, their families, and their caregivers. By choosing the Alzheimer’s Association as our charity of choice for 2024, we are committing to support an organization that works tirelessly to advance dementia care and support those affected by Alzheimer’s disease. This cause not only enhances our presence in our communities but also shows solidarity with the many individuals we serve who are directly affected by this disease. The Collective Impact Joining the Alzheimer’s Association community of fundraisers has a profound impact. In FY23, contributions to the Alzheimer’s Association from donors and partners totaled over $374 million, directly supporting those affected by Alzheimer’s and advancing research. The Walk to End Alzheimer’s alone raised $89.5 million, engaging over 300,000 participants. Strategic fundraising efforts across various platforms have shown significant results, demonstrating the power of collective action in the fight against Alzheimer’s. Together, we can make a real difference. What We’re Doing Each Guardian Pharmacy location is encouraged to form a team and connect with their local Alzheimer’s Association chapter. Whether it’s participating in a Walk or Ride to End Alzheimer’s, hosting educational events, or volunteering, each pharmacy’s involvement in their local community can create a meaningful contribution. For example, the Birmingham, Alabama pharmacy team showed incredible community spirit by rallying its employees to support The Alzheimer’s Association’s The Longest Day on June 20th through a baked goods silent auction. This event not only raised funds but also increased awareness about Alzheimer’s disease within their community. [Read more about the Birmingham team’s efforts] Our Goal Our goal for 2024 is for each of our 48+ pharmacy locations and our corporate support services to commit to building a team and getting involved. We recognize that no action is too small to make a big difference in the fight to #ENDALZ. Join Us in the Fight to #ENDALZ We invite everyone to join us in our stand against Alzheimer’s in 2024. Getting involved is easy. Sign up for an Alzheimer’s Event near you, find volunteer opportunities in your community, or start your fundraiser event. By coming together as a community, we can make a significant impact in the fight against Alzheimer’s disease. Join Guardian Pharmacy in supporting the Alzheimer’s Association and help us work towards a future without this devastating condition. Together, we can #ENDALZ.")
Guardian’s Commitment to the Alzheimer’s Association: Making a Difference in 2024 Alzheimer’s disease is a devastating condition that affects millions of people worldwide, particularly older adults. This year, Guardian Pharmacy is proud to announce the Alzheimer’s Association as our charity of choice. We recognize the critical importance of addressing this pervasive disease and supporting those
Antimicrobial Stewardship in Assisted Living: Engaging Residents and FamiliesBy Nicole Barnett, PharmD, BCGP Antimicrobial resistance is a growing global concern, and its effective management requires a comprehensive approach that includes not only healthcare professionals but also the active involvement of residents and families in long-term care and senior living settings. With 30 to 70% of
Guardian Pharmacy Services was proud to participate in Brookdale’s Golf to End Alzheimer’s 2024. The annual event took place at Gaylord Springs Golf Links in Nashville, Tennessee on June 26. Wendy Kallaher, Guardian Pharmacy’s Senior Director of Account Management; Taylor Smalling, Director, Client Strategy; and Tisha Hayes, Regional Facilitator, played alongside Madison Sargent, Brookdale’s Director